| Literature DB >> 26633492 |
Elvira Verduci1, Carlotta Lassandro2,3, Roberta Giacchero4, Vito Leonardo Miniello5, Giuseppe Banderali6, Giovanni Radaelli7.
Abstract
Research findings are inconsistent about improvement of specific cardio-metabolic variables after lifestyle intervention in obese children. The aim of this trial was to evaluate the effect of a 1-year intervention, based on normocaloric diet and physical activity, on body mass index (BMI), blood lipid profile, glucose metabolism and metabolic syndrome. Eighty-five obese children aged ≥6 years were analyzed. The BMI z-score was calculated. Fasting blood samples were analyzed for lipids, insulin and glucose. The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated and insulin resistance was defined as HOMA-IR >3.16. HOMA-β%, quantitative insulin sensitivity check index and triglyceride glucose index were calculated. The metabolic syndrome was defined in accordance with the International Diabetes Federation criteria. At the end of intervention children showed a reduction (mean (95% CI)) in BMI z-score (-0.58 (-0.66; -0.50)), triglycerides (-0.35 (-0.45; -0.25) mmol/L) and triglyceride glucose index (-0.29 (-0.37; -0.21)), and an increase in HDL cholesterol (0.06 (0.01; 0.11) mmol/L). Prevalence of insulin resistance declined from 51.8% to 36.5% and prevalence of metabolic syndrome from 17.1% to 4.9%. Nutritional-behavioral interventions can improve the blood lipid profile and insulin sensitivity in obese children, and possibly provide benefits in terms of metabolic syndrome.Entities:
Keywords: childhood obesity; glucose metabolism; lipid profile; metabolic syndrome; nutritional-behavioral intervention
Mesh:
Substances:
Year: 2015 PMID: 26633492 PMCID: PMC4690072 DOI: 10.3390/nu7125520
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Daily dietary intake of energy, macronutrients and fiber, and overall glycemic index and glycemic load at baseline and at the end of intervention. Values are mean (SD) †.
| Variable | Baseline ( | End of Intervention ( | Recommended Intake [ | |
|---|---|---|---|---|
| Energy | ||||
| kcal/day | 2460.46 (795.84) | 1855.62 (614.31) | <0.001 * | 1380–3330 kcal/day depending on age and sex (6–15 year) |
| kcal/kg/day | 45.43 (18.86) | 34.39 (16.94) | 0.001 * | |
| Protein | ||||
| g/day | 96.32 (29.50) | 71.12 (23.74) | <0.001 * | |
| % Energy | 15.82 (3.02) | 15.54 (3.16) | 0.006 * | 12%–15% Energy |
| Carbohydrates | ||||
| g/day | 332.69 (113.51) | 268.04 (106.59) | <0.001 * | |
| % Energy | 54.20 (7.19) | 58.07 (9.62) | 0.001 * | 55%–60% Energy |
| Fats | ||||
| g/day | 84.54 (37.94) | 57.27 (21.04) | <0.001 * | |
| % Energy | 31.44 (5.48) | 27.97 (4.16) | <0.001 * | 25%–30% Energy |
| Saturated | ||||
| g/day | 31.64 (14.40) | 19.48 (8.36) | <0.001 * | |
| % Energy | 11.69 (3.07) | 9.44 (3.15) | <0.001 * | <10% Energy |
| Monounsaturated | ||||
| g/day | 34.53 (15.49) | 22.31 (9.28) | <0.001 * | |
| % Energy | 12.64 (2.87) | 10.80 (3.52) | 0.022 * | ≤15% Energy |
| Polyunsaturated | ||||
| g/day | 14.92 (7.20) | 9.83 (3.93) | <0.001 * | |
| % Energy | 5.40 (1.57) | 4.72 (1.74) | 0.016 * | ≤10% Energy |
| Fiber g/day | 11.30 (5.15) | 17.11 (8.02) | <0.001 * | age (year) plus 5 g–age (year) plus 10 g |
| Overall Glycemic Index | 43.58 (22.42) | 41.57 (22.32) | 0.146 | |
| Glycemic Load | 418.73 (565.56) | 307.56 (377.64) | 0.124 | |
† Mean and p-value adjusted for age and sex; * Statistically significant.
Figure 1Within-subject longitudinal variation of obesity status through the intervention period (figures are number of children). Significance of longitudinal variation was p < 0.0001 (Wilcoxon test).
Blood lipid profile at baseline and at the end of intervention. Values are mean (SD) †.
| Variable | Baseline ( | End of Intervention ( | |
|---|---|---|---|
| Total cholesterol (mmol/L) | 4.40 (0.62) | 4.21 (0.70) | 0.072 |
| LDL cholesterol (mmol/L) | 2.58 (0.58) | 2.50 (0.65) | 0.116 |
| HDL cholesterol (mmol/L) | 1.26 (0.21) | 1.32 (0.26) | 0.034 * |
| Triglycerides (mmol/L) | 1.29 (0.66) | 0.94 (0.40) | 0.024 * |
| Apo A1 (g/L) | 1.33 (0.23) | 1.34 (0.21) | 0.772 |
| Apo B (g/L) | 0.76 (0.19) | 0.70 (0.17) | 0.164 |
| ApoB/ApoA | 0.58 (0.18) | 0.54 (0.16) | 0.546 |
| Triglycerides/HDL cholesterol | 1.13 (0.77) | 0.77 (0.45) | 0.018 * |
| LDL/HDL cholesterol | 2.14 (0.80) | 1.99 (0.76) | 0.181 |
| Total cholesterol/HDL cholesterol | 3.62 (0.95) | 3.34 (0.95) | 0.078 |
LDL, low-density-lipoprotein; HDL, high-density-lipoprotein; Apo A1, apolipoprotein A1; Apo B, apolipoprotein B. SI conversion factors: to convert cholesterol, divide values by 0.0259; to convert triglycerides, divide values by 0.0113; to convert Apo A1 and Apo B divide values by 0.01. † Mean and p-value adjusted for age, sex, baseline BMI z-score. * Statistically significant.
Glucose metabolism variables at baseline and at the end of intervention. Values are mean (SD) † or number of children (percentage).
| Variable | Baseline ( | End of Intervention ( | |
|---|---|---|---|
| Glucose (mmol/L) | 4.78 (0.33) | 4.74 (0.29) | 0.341 |
| Insulin (pmol/L) | 133.28 (102.22) | 98.64 (59.51) | 0.399 |
| HOMA-IR | 4.10 (3.30) | 3.01 (1.92) | 0.281 |
| HOMA-β% | 317.10 (221.23) | 237.61 (123.26) | 0.368 |
| QUICK index | 0.32 (0.03) | 0.33 (0.03) | 0.250 |
| TyG index | 8.38 (0.51) | 8.09 (0.43) | 0.030 * |
| Insulin resistance (yes) | 44 (51.8) | 31 (36.5) | 0.008 *,†† |
HOMA-IR, homeostasis model assessment of insulin resistance; QUICK, quantitative insulin sensitivity check; TyG, triglyceride glucose. SI conversion factors: to convert glucose, divide values by 0.0555; to convert insulin, divide values by 6.945. Insulin resistance (yes): HOMA-IR >3.16. † Mean and p-value adjusted for age, sex, baseline BMI z-score. †† Wilcoxon test. * Statistically significant.
Distribution of children according to International Diabetes Federation criteria for metabolic syndrome † [34,35] at baseline and at the end of intervention. Values are number of children (percentage).
| Baseline ( | End of Intervention ( | ||
|---|---|---|---|
| Metabolic syndrome | 7 (17.1) | 2 (4.9) | 0.025 * |
| Component | |||
| Waist circumference ≥90th percentile | 40 (97.6) | 39 (95.1) | 0.317 |
| Triglycerides ≥1.7 mmol/L | 10 (24.4) | 3 (7.3) | 0.008 * |
| HDL cholesterol <1.03 mmol/L | 12 (29.3) | 7 (17.1) | 0.025 * |
| Blood pressure: Systolic ≥130/Diastolic ≥85 mmHg | 9 (22) | 3 (7.3) | 0.034 * |
| Glucose ≥5.6 mmol/L | 0 (0) | 0 (0) | 1.000 |
HDL, high-density-lipoprotein. SI conversion factors: to convert cholesterol, divide values by 0.0259; to convert triglycerides, divide values by 0.0113. † Evaluated in children aged ≥10 years (20 boys, 21 girls). Diagnosis of metabolic syndrome requires waist circumference ≥90th percentile and two or more of the other components. †† Wilcoxon test. * Statistically significant.